Statement from Colin Brenan, CEO of 1CellBio: Recent Judgment

Mary BowenNews

1CellBio strongly disagrees with the court decision. We remain confident in our position, and we will appeal. 1CellBio continues to believe that 10x Genomics has pursued this lawsuit as part of an ongoing effort to disrupt our business, regardless of the impact this could have on innocent third-party researchers who rely on our unique and distinctive products. We intend to take every legal step necessary to continue to supply and support without limitations our global customers with the tools they require for single-cell analysis while the appeal process progresses.